We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Teva, GSK Want Lamictal Suit Paused To Appeal Class Cert.

Law360 (January 4, 2019, 1:31 PM EST) -- GlaxoSmithKline PLC and Teva Pharmaceutical Industries Ltd. are aiming to dismantle drug wholesalers' newly secured class certification in an antitrust battle centered on the availability of generic options to brand-name epilepsy...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.